Worth reading
43Recurring
Scored from 3 of 5 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Agreements reached under this partnership
Impact on Business Performance
The impact on consolidated financial results for the fiscal year ending March 2027 is currently under review. The company will promptly disclose any revisions to its earnings forecast or other matters requiring disclosure.
Date of board resolution8 July 2026
| Item | Details |
|---|---|
| Date of board resolution | 8 July 2026 |
| Impact on Business Performance | The impact on consolidated financial results for the fiscal year ending March 2027 is currently under review. The company will promptly disclose any revisions to its earnings forecast or other matters requiring disclosure. |
Items this document does not state (21)
Name of alliance partnerAlliance partner's business activitiesAlliance partner's locationAlliance partner's capitalAlliance partner's net salesAlliance partner's operating incomeType of allianceDetails of the allianceNumber of shares acquiredAcquisition priceShareholding ratioOverview of the joint ventureOwnership ratioDispatch of directors and officersContract PeriodNumerical targets under the allianceShareholding PolicyContract DateAlliance start dateShare Acquisition Date and Payment DateChange in major shareholders
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The initiative is intended to address challenges related to the stability of product supplies and procurement and sales costs arising from dependence on overseas products, and to promote the adoption of regenerative medicine by enabling medical institutions to introduce domestically produced equipment without purchasing it, thereby reducing the initial implementation burden.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.